BIOMAT Database Logo BIOMAT Database Logo

Dose modification for safe treatment of a compound complex heterozygous DPYD variant carrier with 5-fluorouracil. 2018

Shikshya Shrestha, and Erin E Tapper, and Colbren Scout Trogstad-Isaacson, and Timothy J Hobday, and Steven M Offer, and Robert B Diasio
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.

UI MeSH Term Description Entries

Related Publications

Shikshya Shrestha, and Erin E Tapper, and Colbren Scout Trogstad-Isaacson, and Timothy J Hobday, and Steven M Offer, and Robert B Diasio
Treatment Algorithm for Homozygous or Compound Heterozygous DPYD Variant Allele Carriers With Low-Dose Capecitabine.
November 2017, JCO precision oncology,
Shikshya Shrestha, and Erin E Tapper, and Colbren Scout Trogstad-Isaacson, and Timothy J Hobday, and Steven M Offer, and Robert B Diasio
Precision fluoropyrimidines dosing in a compound heterozygous variant carrier of the DPYD gene: a case report.
May 2023, Cancer chemotherapy and pharmacology,
Shikshya Shrestha, and Erin E Tapper, and Colbren Scout Trogstad-Isaacson, and Timothy J Hobday, and Steven M Offer, and Robert B Diasio
Risk of Toxicity From Topical 5-Fluorouracil Treatment in Patients Carrying DPYD Variant Alleles.
March 2024, Clinical pharmacology and therapeutics,
Shikshya Shrestha, and Erin E Tapper, and Colbren Scout Trogstad-Isaacson, and Timothy J Hobday, and Steven M Offer, and Robert B Diasio
Use of Uridine Triacetate to Reverse Severe Persistent Myelosuppression Following 5-fluorouracil Exposure in a Patient With a c.557A>G Heterozygous DPYD Variant.
September 2021, Clinical colorectal cancer,
Shikshya Shrestha, and Erin E Tapper, and Colbren Scout Trogstad-Isaacson, and Timothy J Hobday, and Steven M Offer, and Robert B Diasio
Modification of trabeculectomy with single-dose intraoperative 5-Fluorouracil application.
February 1998, Acta ophthalmologica Scandinavica,
Shikshya Shrestha, and Erin E Tapper, and Colbren Scout Trogstad-Isaacson, and Timothy J Hobday, and Steven M Offer, and Robert B Diasio
[Variant angina in peroral treatment with 5-fluorouracil].
May 1988, Lakartidningen,
Shikshya Shrestha, and Erin E Tapper, and Colbren Scout Trogstad-Isaacson, and Timothy J Hobday, and Steven M Offer, and Robert B Diasio
A new DPYD genotyping assay for improving the safety of 5-fluorouracil therapy.
December 2012, Clinica chimica acta; international journal of clinical chemistry,
Shikshya Shrestha, and Erin E Tapper, and Colbren Scout Trogstad-Isaacson, and Timothy J Hobday, and Steven M Offer, and Robert B Diasio
Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic DPYD structural variant.
February 2020, Cold Spring Harbor molecular case studies,
Shikshya Shrestha, and Erin E Tapper, and Colbren Scout Trogstad-Isaacson, and Timothy J Hobday, and Steven M Offer, and Robert B Diasio
Aberrant methylation of DPYD promoter, DPYD expression, and cellular sensitivity to 5-fluorouracil in cancer cells.
October 2004, Clinical cancer research : an official journal of the American Association for Cancer Research,
Shikshya Shrestha, and Erin E Tapper, and Colbren Scout Trogstad-Isaacson, and Timothy J Hobday, and Steven M Offer, and Robert B Diasio
Layered inorganic nanocomposites: a promising carrier for 5-fluorouracil (5-FU).
May 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Copied contents to your clipboard!